Three Automations Providers and DMEs can build with ChatGPT and Claude today
CMSLocal Coverage Determination (LCD)

CMS Hospice - Liver Disease Form


Hospice - Liver Disease

Notes: Documentation of additional supporting factors such as progressive malnutrition, muscle wasting, active alcoholism, hepatocellular carcinoma, HBsAg positivity, or hepatitis C refractory to interferon treatment will support eligibility for hospice care.

Indications

(654726) Has the patient been certified by a physician to have a life expectancy of six months or less if the terminal illness runs its normal course? 
(654727) Does the patient have a prothrombin time prolonged more than 5 seconds over control, or an International Normalized Ratio (INR) greater than 1.5? 
(654728) Does the patient have a serum albumin level less than 2.5 gm/dl? 
(654729) Does the patient present with end stage liver disease and at least one of the following: refractory ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy refractory to treatment, or recurrent variceal bleeding despite intensive therapy? 
(654730) For patients not meeting the above criteria, are there other comorbidities or evidence of rapid decline that justify hospice care? 

YesNoN/A
YesNoN/A

Sign up to see the rest of the questions

Unlock the remaining questions and the full coverage workflow.

Sign up for free
Effective Date

10/24/2019

Last Reviewed

10/18/2019

Original Document

  Reference



Background for this Policy

Summary Of Evidence

N/A

Analysis of Evidence

N/A

Medicare coverage of hospice care depends upon a physician’s certification of an individual’s prognosis of a life expectancy of six months or less if the terminal illness runs its normal course. Recognizing that determination of life expectancy during the course of a terminal illness is difficult, this A/B Medicare Administrative Contractor (MAC)(HHH) has established medical criteria for determining prognosis for non-cancer diagnoses. These criteria form a reasonable approach to the determination of life expectancy based on available research, and may be revised as more research is available. Coverage of hospice care for patients not meeting the criteria in this policy may be denied. However, some patients may not meet the criteria, yet still be appropriate for hospice care because of other comorbidities or rapid decline. Coverage for these patients may be approved on an individual consideration basis.

Patients will be considered to be in the terminal stage of liver disease (life expectancy of 6 months or less) if they meet the following criteria (1 and 2 must be present; factors from 3 will lend supporting documentation):

1. The patient should show both a and b:

    a. Prothrombin time prolonged more than 5 seconds over control, or International Normalized Ratio (INR)> 1.5

        b. Serum albumin <2.5 gm/dl

 2. End stage liver disease is present and the patient shows at least one of the following:

       a. Ascites, refractory to treatment or patient non-compliance

       b. Spontaneous bacterial peritonitis

       c. Hepatorenal syndrome (elevated creatinine and blood urea nitrogen (BUN) with oliguria (<400 ml/day) urine and sodium concentration <10 mEq/l)

       d. Hepatic encephalopathy, refractory to treatment, or patient non-compliance

       e. Recurrent variceal bleeding, despite intensive therapy

 3. Documentation of the following factors will support eligibility for hospice care:

       a. Progressive malnutrition

       b. Muscle wasting with reduced strength and endurance

       c. Continued active alcoholism (> 80 gm ethanol/day)

       d. Hepatocellular carcinoma

       e. Hepatitis B virus surface antigen (HBsAg)positivity

       f. Hepatitis C refractory to interferon treatment.

Patients awaiting liver transplant who otherwise fit the above criteria may be certified for the Medicare hospice benefit, but if a donor organ is procured, the patient must be discharged from hospice.